Physician profile
Joseph Yang
NPI 1003254137
$2,208.50
in general payments reported to CMS, 2019-2025
9 companies · $55.62 in 2025
The $55.62 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,541 · 2020: $146 · 2021: $142 · 2022: $165 · 2023: $131 · 2024: $28.23 · 2025: $55.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,559.89 | 2019-2021 | |
| Nobel Biocare USA | $334.05 | 2021-2023 | Nobelactive |
| Straumann USA LLC | $121.16 | 2020-2022 | |
| Cathworks, INC. | $57.61 | 2019 | |
| Henry Schein, INC. | $29.84 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Teleflex LLC | $29.00 | 2019 | |
| Shockwave Medical, INC | $28.23 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $25.78 | 2025 | Optis |
| Pacira Pharmaceuticals Incorporated | $22.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.